{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:25:15Z","timestamp":1789010715893,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"vor","delay-in-days":102,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017317","name":"Catholic Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.gastha.2022.04.007","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T19:25:32Z","timestamp":1650050732000},"page":"618-626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Worldwide Incidence and Mortality of Biliary Tract Cancer"],"prefix":"10.1016","volume":"1","author":[{"given":"Katherine","family":"Baria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico N.","family":"De Toni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoxin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaum M.","family":"Kabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Malvezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastha.2022.04.007_bib1","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.2147\/CMAR.S157092","article-title":"Biliary tract cancers: current knowledge, clinical candidates and future challenges","volume":"11","author":"Tariq","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.gastha.2022.04.007_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2022.04.007_bib3","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1158\/0008-5472.CAN-19-0459","article-title":"Anthropometric risk factors for cancers of the biliary tract in the biliary tract cancers pooling project","volume":"79","author":"Jackson","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.gastha.2022.04.007_bib4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000453013","article-title":"Epidemiology and risk factors of cholangiocarcinoma","volume":"32","author":"Kirstein","year":"2016","journal-title":"Visc Med"},{"key":"10.1016\/j.gastha.2022.04.007_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.21037\/cco.2019.07.12","article-title":"Gallbladder cancer in South America: epidemiology and prevention","volume":"8","author":"Salazar","year":"2019","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.gastha.2022.04.007_bib6","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/jnci\/djz103","article-title":"Smoking, alcohol, and biliary tract cancer risk: a pooling project of 26 prospective studies","volume":"111","author":"McGee","year":"2019","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.gastha.2022.04.007_bib7","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41416-020-0987-3","article-title":"Current and novel therapeutic opportunities for systemic therapy in biliary cancer","volume":"123","author":"Marin","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.gastha.2022.04.007_bib8","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.ejca.2015.07.034","article-title":"Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: results of EUROCARE-5","volume":"51","author":"Lepage","year":"2015","journal-title":"Eur J Cancer"},{"issue":"Suppl 3","key":"10.1016\/j.gastha.2022.04.007_bib9","first-page":"2469","article-title":"Biliary tract cancer (BTC) epidemiology in the United States","volume":"29","author":"Wang","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.gastha.2022.04.007_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jhep.2019.03.013","article-title":"Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma","volume":"71","author":"Bertuccio","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gastha.2022.04.007_bib11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cgh.2017.08.017","article-title":"Worldwide burden of and trends in mortality from gallbladder and other biliary tract cancers","volume":"16","author":"Torre","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2022.04.007_bib12","author":"Bray"},{"key":"10.1016\/j.gastha.2022.04.007_bib13","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/cncr.33476","article-title":"The global, regional, and national burden of gallbladder and biliary tract cancer and its attributable risk factors in 195 countries and territories, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"127","author":"Ouyang","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.gastha.2022.04.007_bib14","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jhep.2011.11.015","article-title":"Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?","volume":"56","author":"Khan","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gastha.2022.04.007_bib17","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1097\/MPG.0000000000001749","article-title":"Cholangiocarcinoma among children and adolescents: a review of the literature and surveillance, epidemiology, and end results program database analysis","volume":"66","author":"Newsome","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gastha.2022.04.007_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5009\/gnl18105","article-title":"Incidence and overall survival of biliary tract cancers in South Korea from 2006 to 2015: using the National Health Information Database","volume":"13","author":"Kim","year":"2019","journal-title":"Gut Liver"},{"key":"10.1016\/j.gastha.2022.04.007_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5114\/ceh.2019.85166","article-title":"Epidemiology of gallbladder cancer","volume":"5","author":"Rawla","year":"2019","journal-title":"Clin Exp Hepatol"},{"key":"10.1016\/j.gastha.2022.04.007_bib20","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/jgh.15066","article-title":"The impact of age and comorbidity in advanced or recurrent biliary tract\u00a0cancer receiving palliative chemotherapy","volume":"35","author":"Takahara","year":"2020","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2022.04.007_bib21","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1572-0241.2007.01104.x","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study","volume":"102","author":"Shaib","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2022.04.007_bib22","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/jvh.13304","article-title":"Incidence of extrahepatic cancers among individuals with chronic hepatitis B or C virus infection: a nationwide cohort study","volume":"27","author":"Hong","year":"2020","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.gastha.2022.04.007_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1442-200x.2004.01867.x","article-title":"Molecular epidemiology of hepatitis B and C virus infections in Asia","volume":"46","author":"Huy","year":"2004","journal-title":"Pediatr Int"},{"key":"10.1016\/j.gastha.2022.04.007_bib24","first-page":"197","article-title":"Cholangiocarcinoma trends, incidence, and relative survival in Khon Kaen, Thailand from 1989 through 2013: a population-based cancer registry study","volume":"29","author":"Kamsa-Ard","year":"2019","journal-title":"J\u00a0Epidemiol"},{"key":"10.1016\/j.gastha.2022.04.007_bib25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40249-018-0434-3","article-title":"Thinking beyond Opisthorchis viverrini for risk of cholangiocarcinoma in the lower Mekong region: a systematic review and meta-analysis","volume":"7","author":"Steele","year":"2018","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.gastha.2022.04.007_bib26","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1002\/oby.21505","article-title":"Overweight, obesity and the risk of gallbladder and extrahepatic bile duct cancers: a meta-analysis of observational studies","volume":"24","author":"Li","year":"2016","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.gastha.2022.04.007_bib27","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s41395-018-0207-4","article-title":"Body mass index, diabetes and intrahepatic cholangiocarcinoma risk: the Liver Cancer Pooling Project and meta-analysis","volume":"113","author":"Petrick","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2022.04.007_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12876-017-0696-4","article-title":"Non-alcoholic fatty liver disease as a risk factor for\u00a0cholangiocarcinoma: a systematic review and meta-analysis","volume":"17","author":"Wongjarupong","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.gastha.2022.04.007_bib29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000337314","article-title":"Obesity, diabetes, the cardiorenal syndrome, and risk for cancer","volume":"2","author":"Forte","year":"2012","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.gastha.2022.04.007_bib30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7861\/clinmedicine.18-3-245","article-title":"Non-alcoholic fatty liver disease","volume":"18","author":"Maurice","year":"2018","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.gastha.2022.04.007_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.21037\/cco.2016.10.09","article-title":"Biliary tract cancers: epidemiology, molecular pathogenesis and genetic risk associations","volume":"5","author":"Marcano-Bonilla","year":"2016","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.gastha.2022.04.007_bib32","first-page":"99","article-title":"Gallbladder cancer: epidemiology and outcome","volume":"6","author":"Hundal","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.gastha.2022.04.007_bib33","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.canep.2016.07.021","article-title":"Burden of gallbladder cancer in Central and South America","volume":"44 Suppl 1","author":"Izarzugaza","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.gastha.2022.04.007_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.21037\/cco.2019.08.03","article-title":"Epidemiology of gallbladder cancer in India","volume":"8","author":"Dutta","year":"2019","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.gastha.2022.04.007_bib35","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/ijc.32863","article-title":"Gallbladder and extrahepatic bile duct cancers in the Americas: incidence and mortality patterns and trends","volume":"147","author":"Miranda-Filho","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gastha.2022.04.007_bib36","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.gdata.2014.08.007","article-title":"The miRNAome of Opisthorchis viverrini induced intrahepatic cholangiocarcinoma","volume":"2","author":"Peng","year":"2014","journal-title":"Genom Data"},{"key":"10.1016\/j.gastha.2022.04.007_bib37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00330-019-06317-2","article-title":"Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017","volume":"30","author":"Li","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.gastha.2022.04.007_bib38","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/gutjnl-2017-314981","article-title":"Non-invasive diagnosis of hepatocellular carcinoma revisited","volume":"67","author":"Mueller","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.gastha.2022.04.007_bib39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","article-title":"Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Benson","year":"2021","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.gastha.2022.04.007_bib40","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.gastha.2022.04.007_bib41","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1470-2045(20)30157-1","article-title":"Ivosidenib in\u00a0IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.gastha.2022.04.007_bib42","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","article-title":"Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572322000607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572322000607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T11:33:44Z","timestamp":1757417624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572322000607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"alternative-id":["S2772572322000607"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2022.04.007","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Worldwide Incidence and Mortality of Biliary Tract Cancer","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2022.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute","name":"copyright","label":"Copyright"}]}}